Meilan Zhou

578 total citations
32 papers, 378 citations indexed

About

Meilan Zhou is a scholar working on Nephrology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Meilan Zhou has authored 32 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 8 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Meilan Zhou's work include Acute Kidney Injury Research (6 papers), Tuberculosis Research and Epidemiology (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Meilan Zhou is often cited by papers focused on Acute Kidney Injury Research (6 papers), Tuberculosis Research and Epidemiology (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). Meilan Zhou collaborates with scholars based in China and United States. Meilan Zhou's co-authors include Lijuan Zhao, Ye Wang, Zhu Wang, Ming Bai, Feng Ma, Lijie He, Yangping Li, Yan Yu, Shiren Sun and Rui Jing and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Meilan Zhou

31 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meilan Zhou China 8 178 67 56 50 46 32 378
Weijia Xu China 8 257 1.4× 61 0.9× 43 0.8× 25 0.5× 81 1.8× 13 436
Ramin Tolouian United States 11 138 0.8× 85 1.3× 28 0.5× 38 0.8× 59 1.3× 40 502
Xiaobing Yang China 13 311 1.7× 45 0.7× 63 1.1× 44 0.9× 132 2.9× 19 568
Fumihiko Hinoshita Japan 12 75 0.4× 60 0.9× 51 0.9× 31 0.6× 70 1.5× 52 424
Ha Nee Jang South Korea 11 106 0.6× 60 0.9× 72 1.3× 31 0.6× 67 1.5× 51 397
Gaosi Xu China 16 303 1.7× 78 1.2× 51 0.9× 81 1.6× 135 2.9× 65 816
Hyun Seop Cho South Korea 12 75 0.4× 49 0.7× 65 1.2× 24 0.5× 53 1.2× 38 363
Aida Lydia Indonesia 12 158 0.9× 49 0.7× 34 0.6× 23 0.5× 55 1.2× 39 379
Houssem Hmouda Tunisia 10 144 0.8× 99 1.5× 70 1.3× 72 1.4× 95 2.1× 20 593
Luca Cioccari Switzerland 13 100 0.6× 158 2.4× 112 2.0× 11 0.2× 56 1.2× 42 449

Countries citing papers authored by Meilan Zhou

Since Specialization
Citations

This map shows the geographic impact of Meilan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meilan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meilan Zhou more than expected).

Fields of papers citing papers by Meilan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meilan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meilan Zhou. The network helps show where Meilan Zhou may publish in the future.

Co-authorship network of co-authors of Meilan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Meilan Zhou. A scholar is included among the top collaborators of Meilan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meilan Zhou. Meilan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Lijuan, Zixian Yu, Jin Zhao, et al.. (2024). Comparison of different peritoneal dialysis catheters on complications and catheter survival: A network meta-analysis of randomised controlled trials. Peritoneal Dialysis International. 45(1). 35–43.
2.
Kan, Yongjun, et al.. (2024). Response of Soil Microorganisms and Phenolic to Pseudostelariae heterophylla Cultivation in Different Soil Types. Eurasian Soil Science. 57(3). 446–459. 4 indexed citations
3.
Zhang, Zhengbin, Gang Wu, Jing Hu, et al.. (2024). Epidemiological characteristics and influencing factors of tuberculosis aggregation in schools in Wuhan, China during 2017–2022. Frontiers in Public Health. 12. 1365983–1365983. 1 indexed citations
4.
Huang, Hai, Zongqi Zhang, Gang Wu, et al.. (2024). Deciphering the role of cuproptosis‐related lncRNAs in shaping the lung cancer immune microenvironment: A comprehensive prognostic model. Journal of Cellular and Molecular Medicine. 28(13). e18519–e18519. 5 indexed citations
5.
Wang, Xiaojun, et al.. (2023). How Integrated Digital Tools Can Improve Tuberculosis Medication Adherence: A Longitudinal Study in China. Telemedicine Journal and e-Health. 30(2). 490–498. 3 indexed citations
7.
Liu, Junhui, Zhengbin Zhang, Meilan Zhou, et al.. (2023). Identification of the novel markers of PPAR signalling affecting immune microenvironment and immunotherapy response of lung adenocarcinoma patients. Journal of Cellular and Molecular Medicine. 28(5). e17877–e17877. 1 indexed citations
8.
Wang, Jiaming, Yu Zhang, Weijie Liu, & Meilan Zhou. (2022). Research on energy management of hybrid power system in fuel cell vehicles. International Journal of Electric and Hybrid Vehicles. 14(1/2). 154–154. 1 indexed citations
9.
Chen, Jun, Lifeng Chen, Meng Zhou, et al.. (2022). Transmission of multidrug-resistant tuberculosis within family households by DTM-PCR and MIRU-VNTR genotyping. BMC Infectious Diseases. 22(1). 192–192. 5 indexed citations
10.
Ma, Feng, Xiaoxia Yang, Meilan Zhou, et al.. (2020). Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide. Journal of Nephrology. 33(6). 1241–1250. 9 indexed citations
11.
Wang, Yan, Xiaoxuan Ning, Ming Bai, et al.. (2020). A comparative study of cyclophosphamide, thalidomide and dexamethasone (CTD) versus bortezomib and dexamethasone (BDex) in light-chain amyloidosis. Current Problems in Cancer. 45(2). 100669–100669. 1 indexed citations
13.
Wang, Di, Meilan Zhou, Yan Wang, & Shiren Sun. (2020). Suppression of high-mobility group box 1 ameliorates xerostomia in a Sjögren syndrome-triggered mouse model. Canadian Journal of Physiology and Pharmacology. 98(6). 351–356. 10 indexed citations
16.
Liu, An, Qiong Song, Chen Huang, et al.. (2019). Expression of XBP1s in peritoneal mesothelial cells is critical for inflammation-induced peritoneal fibrosis. Scientific Reports. 9(1). 19043–19043. 5 indexed citations
17.
Du, Juan, et al.. (2017). Effect of type 2 diabetes mellitus on sputum negative conversion and treatment effects of multi-drug-resistant tuberculosis. Biomedical Research-tokyo. 28(9). 3917–3922. 5 indexed citations
18.
Liu, Yirong, Ming Bai, Yangping Li, et al.. (2016). The Reduction Rate of Serum Sodium and Mortality in Patients Undergoing Continuous Venovenous Hemofiltration for Acute Severe Hypernatremia. The American Journal of the Medical Sciences. 352(3). 272–279. 3 indexed citations
19.
Bai, Ming, Yangping Li, Yan Yu, et al.. (2015). Continuous Venovenous Hemofiltration (CVVH) Versus Conventional Treatment for Acute Severe Hypernatremia in Critically Ill Patients. Shock. 44(5). 445–451. 9 indexed citations
20.
Wang, Hanmin, et al.. (2012). Successful Treatment of Multiple Organ Failure After Wasp Stings in an Elderly Patient. SHILAP Revista de lepidopterología. 6(1). 52–53. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026